Affinity DataIC50: 1.60nMpH: 8.0 T: 2°CAssay Description:For the enzyme assay, the enzyme fraction was added to fluorescent substrate in the presence of test compounds, and the mixture was incubated for add...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60nMpH: 8.0 T: 2°CAssay Description:For the enzyme assay, the enzyme fraction was added to fluorescent substrate in the presence of test compounds, and the mixture was incubated for add...More data for this Ligand-Target Pair
Affinity DataIC50: 1.76nMAssay Description:The assay is described in WO2008/062201.More data for this Ligand-Target Pair
Affinity DataIC50: 3.97nMpH: 8.0 T: 2°CAssay Description:For the enzyme assay, the enzyme fraction was added to fluorescent substrate in the presence of test compounds, and the mixture was incubated for add...More data for this Ligand-Target Pair
Affinity DataIC50: 4.40nMT: 2°CAssay Description:In vitro HDAC assays were performed using a HDAC fluorescent activity assay kit (Biomol, UK) according to the manufacturer's instructions. Compounds ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 5nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 7nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 10nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 15nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
Affinity DataIC50: 17.5nMpH: 8.0 T: 2°CAssay Description:For the enzyme assay, the enzyme fraction was added to fluorescent substrate in the presence of test compounds, and the mixture was incubated for add...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 19nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 21nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 21.6nMT: 2°CAssay Description:In vitro HDAC assays were performed using a HDAC fluorescent activity assay kit (Biomol, UK) according to the manufacturer's instructions. Compounds ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 22nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 25nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 26nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 33nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
Affinity DataIC50: 47nMT: 2°CAssay Description:In vitro HDAC assays were performed using a HDAC fluorescent activity assay kit (Biomol, UK) according to the manufacturer's instructions. Compounds ...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 54nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 57nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 63nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 64nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 69nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent
Affinity DataIC50: 83nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics
US Patent
Karus Therapeutics
US Patent